Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel Fragment
OwnerKim Nicholas Green, Tilman Oltersdorf +1inventors
InventorsKim Nicholas Green, Tilman Oltersdorf, Eckard Weber
Life of this patent
Estimating the term…
Loading patent…
OwnerKim Nicholas Green, Tilman Oltersdorf +1inventors
InventorsKim Nicholas Green, Tilman Oltersdorf, Eckard Weber
Estimating the term…
The present invention provides a method of inducing cleavage of amyloid precursor protein to produce an approximately 17 kilodalton carboxy-terminal fragment of amyloid precursor protein in a subject, the method comprising administering a heterocyclic compound or a pharmaceutically acceptable salt, hydrate or prodrug thereof to a subject in need thereof, wherein the approximately 17 kilodalton fragment includes the carboxyterminal amino acid sequence of amyloid precursor protein and amyloid-beta amino acid sequence. Also provided is a screening method for identifying compounds induce cleavage of amyloid precursor protein to produce the approximately 17 kilodalton carboxy-terminal fragment of amyloid precursor protein.
A method of inducing cleavage of amyloid precursor protein to produce an approximately 17 kilodalton carboxy-terminal fragment of amyloid precursor protein in a subject, the method comprising administering a heterocyclic compound having the general Formula (I):
An isolated approximately 17 kilodalton amyloid precursor protein fragment that includes the carboxyterminal amino acid sequence of amyloid precursor protein and amyloid-beta amino acid sequence.
A method for screening for a compound that cleaves amyloid precursor protein to generate an approximately 17 kilodalton fragment of amyloid precursor protein, said method comprising:
A method for screening for a compound that cleaves amyloid precursor protein to generate an approximately 17 kilodalton fragment of APP, the method comprising:
A method of inducing cleavage of amyloid precursor protein to produce an approximately 17 kilodalton carboxy-terminal fragment of amyloid precursor protein in a subject, the method comprising administering a compound that is not a compound having the general Formula (I):
Dependencies are inferred from the claim text.